Showing results (581-590 of 695) with videos related to

Sort By:
Pageof 70
Research Square|July 28, 2023
Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer's Disease in Real-World Clinical DatasetsWei-Qi Wei, Chao Yan, Monika Grabowska, et al.
European Journal of Pain (London, England)|February 10, 2017
Ankyrin-rich membrane spanning protein as a novel modulator of transient receptor potential vanilloid 1-function in nociceptive neuronsJ Peter, C Kasper, M Kaufholz, et al.
Clinical Neurology and Neurosurgery|January 24, 2016
Long-term quality of life after posterior cervical foraminotomy for radiculopathyRyan W Faught, Ephraim W Church, Casey H Halpern, et al.
British Journal of Cancer|February 1, 1991
The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]R C Stein, V Malkovska, S Morgan, et al.
The Journal of Surgical Research|April 23, 2014
Perioperative changes in trunk musculature and postoperative outcomesArya Zarinsefat, Michael N Terjimanian, Kyle H Sheetz, et al.
Nature Communications|January 6, 2026
Defining expansions and perturbations to the RNA polymerase III transcriptome and epitranscriptome by modified direct RNA nanopore sequencingRuth Verstraten, Pierina Cetraro, Amy H Fitzpatrick, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|October 31, 2012
Endoscopic versus open resection of tuberculum sellae meningiomas: a decision analysisLeif-Erik Bohman, Sherman C Stein, Jason G Newman, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Defining expansions and perturbations to the RNA polymerase III transcriptome and epitranscriptome by modified direct RNA nanopore sequencingRuth Verstraten, Pierina Cetraro, Amy H Fitzpatrick, et al.
The New England Journal of Medicine|September 11, 2009
Asymptomatic reactivation of JC virus in patients treated with natalizumabYiping Chen, Evelyn Bord, Troy Tompkins, et al.
Science (New York, N.Y.)|March 4, 2017
A nontoxic pain killer designed by modeling of pathological receptor conformationsV Spahn, G Del Vecchio, D Labuz, et al.
Pageof 70